Sophie Susen

Lille, FR

Expertise in

conditions

Lille, FR

OverviewLocationsClinical Research

Overview

Sophie Susen practices in Lille, France. Ms. Susen is highly rated in 13 conditions, according to our data. Her top areas of expertise are Von Willebrand Disease (VWD), Blood Clots, Hemophilia A, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR).

Her clinical research consists of co-authoring 165 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender

Female

Locations

Lille, 59000, France

Other Locations

Bordeaux, France

Paris, France

France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Global, Open-Label, Multicenter, Phase 1/2 Study of the Safety and Dose Escalation of BAX 888, an Adeno-Associated Virus Serotype 8 (AAV8) Vector Expressing B-Domain Deleted Factor VIII (BDD-FVIII) in Severe Hemophilia A Subjects Administered a Single Intravenous Infusion

Enrollment Status: Completed

Publish Date: September 11, 2025

Intervention Type: Drug

Study Drug: BAX-888 Adeno-Associated Virus Serotype 8 Vector B-Domain Deleted Factor VIII Vaccine

Study Phase: Phase 1/Phase 2

Phase 3, Prospective, Multi-center, Open Label Study to Investigate Safety, Immunogenicity and Hemostatic Efficacy of PEGylated Factor VIII (BAX 855) in Previously Untreated Patients (PUPs) < 6 Years With Severe Hemophilia A (FVIII < 1%)

Enrollment Status: Completed

Publish Date: July 28, 2025

Intervention Type: Biological

Study Drugs: PEG-Factor VIII, Eloctate ITI

Study Phase: Phase 3

An Interventional Randomized Controlled Trial of the Quantra® System With the QStat® Cartridge in Trauma

Enrollment Status: Terminated

Publish Date: March 14, 2025

Intervention Type: Diagnostic test

PCR-COVID-19 Predictors of Positivity in Patients Admitted to ICU for Respiratory Infection: A Prospective Observational Cohort Study

Enrollment Status: Completed

Publish Date: December 06, 2023

Observatory of Invasive Procedures and Bleeding in Patients Treated With New Oral Anticoagulants

Enrollment Status: Completed

Publish Date: October 06, 2021

Intervention Type: Other

View 4 Less Clinical Trials

165 Total Publications

Hydroxychloroquine does not affect endotheliopathy or coagulopathy biomarkers in COVID-19: longitudinal results from the DisCoVeRy randomized trial.

Journal: Angiogenesis

Published: October 23, 2025

View All 165 Publications

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Susen's expertise for a condition

ConditionClose